Efgartigimod alfa Uses, Dosage, Side Effects and more
Efgartigimod alfa is under investigation in clinical trial NCT03669588 (An Efficacy and Safety Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness).
Trade Name | Efgartigimod alfa |
Generic | Efgartigimod alfa |
Efgartigimod alfa Other Names | Efgartigimod alfa |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |